(Q43275327)

18 November 2017

title

Genetic variations of NAT2 and CYP2E1 and isoniazid hepatotoxicity in a diverse population (English)

1 reference

18 November 2017

1 reference

0 references

10

Fawziah Marra

1 reference

18 November 2017

6

Victoria J Cook

1 reference

18 November 2017

So Yamada

1

1 reference

18 November 2017

Mila Tang

2

1 reference

18 November 2017

Kathryn Richardson

3

1 reference

18 November 2017

Julius Halaschek-Wiener

4

1 reference

18 November 2017

Matthew Chan

5

1 reference

18 November 2017

J Mark Fitzgerald

7

1 reference

18 November 2017

R Kevin Elwood

8

1 reference

18 November 2017

Angela Brooks-Wilson

9

1 reference

18 November 2017

publication date

1 September 2009

1 reference

18 November 2017

1 reference

18 November 2017

volume

10

1 reference

18 November 2017

issue

9

1 reference

18 November 2017

page(s)

1433-1445

1 reference

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project

18 November 2017

cites work

1 reference

Hepatotoxicity of antitubercular treatments. Rationale for monitoring liver status

21 January 2018

1 reference

Liver injury during antituberculosis treatment: an 11-year study

21 January 2018

1 reference

An analysis of decisions by European general practitioners to admit to hospital patients with lower respiratory tract infections. The European Study Group of Community Acquired Pneumonia (ESOCAP) of the European Respiratory Society

21 January 2018

1 reference

Clinical study of cryoglobulinaemia in Chinese patients with chronic hepatitis C

21 January 2018

1 reference

Risk factors for hepatotoxicity from antituberculosis drugs: a case-control study

21 January 2018

1 reference

Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis

21 January 2018

1 reference

Toxic hepatitis with isoniazid and rifampin. A meta-analysis

21 January 2018

1 reference

Trimodality of isoniazid elimination: phenotype and genotype in patients with tuberculosis

21 January 2018

1 reference

Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis

21 January 2018

1 reference

The influence of NAT2 genotypes on the plasma concentration of isoniazid and acetylisoniazid in Chinese pulmonary tuberculosis patients

21 January 2018

1 reference

CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis

21 January 2018

1 reference

Pharmacogenomics of anti-TB drugs-related hepatotoxicity

21 January 2018

1 reference

Polymorphisms of promoter and coding regions of the arylamine N-acetyltransferase 2 (NAT2) gene in the Indonesian population: proposal for a new nomenclature.

21 January 2018

1 reference

Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis

21 January 2018

1 reference

The current state of serum biomarkers of hepatotoxicity.

21 January 2018

1 reference

Criteria of drug-induced liver disorders. Report of an international consensus meeting

21 January 2018

1 reference

Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries

21 January 2018

1 reference

VISTA: computational tools for comparative genomics

21 January 2018

1 reference

Conserved Noncoding Sequences among Cultivated Cereal Genomes Identify Candidate Regulatory Sequence Elements and Patterns of Promoter Evolution[W]

21 January 2018

1 reference

Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria

21 January 2018

1 reference

PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing

21 January 2018

1 reference

Consed: a graphical tool for sequence finishing

21 January 2018

1 reference

Haploview: analysis and visualization of LD and haplotype maps

21 January 2018

1 reference

Analysis of nucleotide diversity of NAT2 coding region reveals homogeneity across Native American populations and high intra-population diversity

21 January 2018

1 reference

Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous

21 January 2018

1 reference

Functional evolution of noncoding DNA.

21 January 2018

1 reference

Genetic polymorphisms of NAT2 and CYP2E1 associated with antituberculosis drug-induced hepatotoxicity in Korean patients with pulmonary tuberculosis

21 January 2018

1 reference

Identification of single-nucleotide polymorphisms (SNPs) of human N-acetyltransferase genes NAT1, NAT2, AANAT, ARD1 and L1CAM in the Japanese population

21 January 2018

1 reference

Pharmacokinetic factors in the modern drug treatment of tuberculosis.

21 January 2018

1 reference

Inhibitory effect of antituberculosis drugs on human cytochrome P450-mediated activities

21 January 2018

1 reference

Antituberculosis drugs and hepatotoxicity

21 January 2018

1 reference

Inhibition and induction of cytochrome P4502E1-catalyzed oxidation by isoniazid in humans

21 January 2018

1 reference

Preliminary phenotypic map of chromosome 4p16 based on 4p deletions.

21 January 2018

1 reference

The influence of dose and N-acetyltransferase-2 (NAT2) genotype and phenotype on the pharmacokinetics and pharmacodynamics of isoniazid.

21 January 2018

1 reference

Expression of cytochrome P4502E1 in human liver: assessment by mRNA, genotype and phenotype

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/PGS.09.66

1 reference

release_awjkdbecmnajxaapkd5hctiymi

18 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/awjkdbecmnajxaapkd5hctiymi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference